| Michael Jason Justice, DO | |
|
203 Nw Rd Mize Road, Suite #250, Blue Springs, MO 64014 | |
| (816) 220-8727 | |
| (816) 220-8269 |
| Full Name | Michael Jason Justice |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 203 Nw Rd Mize Road, Blue Springs, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861638199 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 2008017228 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Kansas City Hospital | North kansas city, MO | Hospital |
| Excelsior Springs Hospital | Excelsior springs, MO | Hospital |
| Overland Park Reg Med Ctr | Overland park, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excelsior Springs City Hospital | 7315847209 | 20 |
| Orthopedic Surgeons Pa | 8527034123 | 29 |
| Orthopedic Surgeons Pa | 8527034123 | 29 |
News Archive
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation.
Chronic lymphocytic leukemia is a hematological malignancy that originates in the blood-forming cells of the bone marrow and spreads to other organs through the bloodstream.
QIAGEN has completed European certification of its careHPV™ Test to bring human papillomavirus (HPV) testing to public-health programs in low-resource, developing countries, the company announced today at the International Papillomavirus Conference in Montreal, Canada. The CE conformity marking ("Conformite Europeenne") certifies that the careHPV Test has met European Union consumer safety and health requirements, allowing the test to be distributed in developing countries that recognize the CE mark.
HCA's robust profit growth has raised the value of the firms' holdings to nearly three and a half times their initial investment in the $33 billion deal. The financial performance has been so impressive that HCA has become a model for the industry.
In a study conducted at the Monash University, Australia, scientists have examined the efficacy of portable air purifiers combined with a hood in reducing virus aerosol transmission and protecting healthcare workers from workplace contamination. The study is currently available on the medRxiv* preprint server.
› Verified 8 days ago
| Entity Name | Excelsior Springs City Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285733923 PECOS PAC ID: 7315847209 Enrollment ID: O20040108000958 |
News Archive
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation.
Chronic lymphocytic leukemia is a hematological malignancy that originates in the blood-forming cells of the bone marrow and spreads to other organs through the bloodstream.
QIAGEN has completed European certification of its careHPV™ Test to bring human papillomavirus (HPV) testing to public-health programs in low-resource, developing countries, the company announced today at the International Papillomavirus Conference in Montreal, Canada. The CE conformity marking ("Conformite Europeenne") certifies that the careHPV Test has met European Union consumer safety and health requirements, allowing the test to be distributed in developing countries that recognize the CE mark.
HCA's robust profit growth has raised the value of the firms' holdings to nearly three and a half times their initial investment in the $33 billion deal. The financial performance has been so impressive that HCA has become a model for the industry.
In a study conducted at the Monash University, Australia, scientists have examined the efficacy of portable air purifiers combined with a hood in reducing virus aerosol transmission and protecting healthcare workers from workplace contamination. The study is currently available on the medRxiv* preprint server.
› Verified 8 days ago
| Entity Name | Orthopedic Surgeons Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841264835 PECOS PAC ID: 8527034123 Enrollment ID: O20040904000009 |
News Archive
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation.
Chronic lymphocytic leukemia is a hematological malignancy that originates in the blood-forming cells of the bone marrow and spreads to other organs through the bloodstream.
QIAGEN has completed European certification of its careHPV™ Test to bring human papillomavirus (HPV) testing to public-health programs in low-resource, developing countries, the company announced today at the International Papillomavirus Conference in Montreal, Canada. The CE conformity marking ("Conformite Europeenne") certifies that the careHPV Test has met European Union consumer safety and health requirements, allowing the test to be distributed in developing countries that recognize the CE mark.
HCA's robust profit growth has raised the value of the firms' holdings to nearly three and a half times their initial investment in the $33 billion deal. The financial performance has been so impressive that HCA has become a model for the industry.
In a study conducted at the Monash University, Australia, scientists have examined the efficacy of portable air purifiers combined with a hood in reducing virus aerosol transmission and protecting healthcare workers from workplace contamination. The study is currently available on the medRxiv* preprint server.
› Verified 8 days ago
| Entity Name | Liberty Hospital Urgent Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558778373 PECOS PAC ID: 3375866163 Enrollment ID: O20141231001624 |
News Archive
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation.
Chronic lymphocytic leukemia is a hematological malignancy that originates in the blood-forming cells of the bone marrow and spreads to other organs through the bloodstream.
QIAGEN has completed European certification of its careHPV™ Test to bring human papillomavirus (HPV) testing to public-health programs in low-resource, developing countries, the company announced today at the International Papillomavirus Conference in Montreal, Canada. The CE conformity marking ("Conformite Europeenne") certifies that the careHPV Test has met European Union consumer safety and health requirements, allowing the test to be distributed in developing countries that recognize the CE mark.
HCA's robust profit growth has raised the value of the firms' holdings to nearly three and a half times their initial investment in the $33 billion deal. The financial performance has been so impressive that HCA has become a model for the industry.
In a study conducted at the Monash University, Australia, scientists have examined the efficacy of portable air purifiers combined with a hood in reducing virus aerosol transmission and protecting healthcare workers from workplace contamination. The study is currently available on the medRxiv* preprint server.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Jason Justice, DO 2790 Clay Edwards Dr, Suite #650, North Kansas City, MO 64116-3276 Ph: (816) 459-7500 | Michael Jason Justice, DO 203 Nw Rd Mize Road, Suite #250, Blue Springs, MO 64014 Ph: (816) 220-8727 |
News Archive
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation.
Chronic lymphocytic leukemia is a hematological malignancy that originates in the blood-forming cells of the bone marrow and spreads to other organs through the bloodstream.
QIAGEN has completed European certification of its careHPV™ Test to bring human papillomavirus (HPV) testing to public-health programs in low-resource, developing countries, the company announced today at the International Papillomavirus Conference in Montreal, Canada. The CE conformity marking ("Conformite Europeenne") certifies that the careHPV Test has met European Union consumer safety and health requirements, allowing the test to be distributed in developing countries that recognize the CE mark.
HCA's robust profit growth has raised the value of the firms' holdings to nearly three and a half times their initial investment in the $33 billion deal. The financial performance has been so impressive that HCA has become a model for the industry.
In a study conducted at the Monash University, Australia, scientists have examined the efficacy of portable air purifiers combined with a hood in reducing virus aerosol transmission and protecting healthcare workers from workplace contamination. The study is currently available on the medRxiv* preprint server.
› Verified 8 days ago
Dr. Angela K Walker, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 201 Nw R D Mize Rd, Blue Springs, MO 64014 Phone: 816-655-5426 Fax: 816-655-5408 | |
Dr. Derec Stanislav, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 201 Nw Rd Mize Road, Blue Springs, MO 64014 Phone: 816-655-5426 Fax: 816-655-5408 | |
Dr. Elijah G Miller, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 201 Nw Rd Mize Road, Blue Springs, MO 64014 Phone: 816-655-5426 Fax: 816-655-5408 | |
David W Dugan, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 203 Nw R. D. Mize Rd, Suite # 250, Blue Springs, MO 64014 Phone: 816-220-5123 Fax: 816-220-3085 | |
Kevin Andrew Witte, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 203 Nw R.d. Mize Rd, Ste 250, Blue Springs, MO 64014 Phone: 816-220-8727 Fax: 816-220-8269 | |
Dr. Katherine Paul, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 201 Nw Rd Mize Road, Blue Springs, MO 64014 Phone: 816-220-8727 Fax: 816-220-8269 |